Clinical outcomes in non-small-cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors and other targeted therapies based on tumor versus plasma genomic profiling

Hai T. Tran, Vincent K. Lam, Yasir Y. Elamin, Lingzhi Hong, Rivka Colen, Nabil A. Elshafeey, Islam S.A. Hassan, Mehmet Altan, George R. Blumenschein, Waree Rinsurongkawong, Melvin J. Rivera, Mayra E. Vasquez, Brett W. Carter, Lauren E. Byers, Anne S. Tsao, Don L. Gibbons, Frank Fossella, Bonnie S. Glisson, Jianjun Zhang, John V. Heymach

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes in non-small-cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors and other targeted therapies based on tumor versus plasma genomic profiling'. Together they form a unique fingerprint.

Medicine & Life Sciences